Literature DB >> 4274024

Treatment of streptozotocin diabetes with di-isopropylammonium dichloroacetate (DIPA).

H L Eichner, P W Stacpoole, P H Forsham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4274024     DOI: 10.2337/diab.23.3.179

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  5 in total

Review 1.  Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.

Authors:  Margaret O James; Stephan C Jahn; Guo Zhong; Marci G Smeltz; Zhiwei Hu; Peter W Stacpoole
Journal:  Pharmacol Ther       Date:  2016-10-19       Impact factor: 12.310

2.  Dichloroacetate.

Authors: 
Journal:  Br Med J       Date:  1978-08-12

Review 3.  Pharmacogenetic considerations with dichloroacetate dosing.

Authors:  Margaret O James; Peter W Stacpoole
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

4.  Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans.

Authors:  P G Wells; G W Moore; D Rabin; G R Wilkinson; J A Oates; P W Stacpoole
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

5.  Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesis.

Authors:  Yuko Katayama; Yayoi Kawata; Yusuke Moritoh; Masanori Watanabe
Journal:  Heliyon       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.